BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,061 filers reported holding BAXTER INTL INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,478,260 | -18.8% | 171,655 | -2.0% | 0.01% | -20.0% |
Q2 2023 | $7,978,103 | -1.6% | 175,112 | -12.4% | 0.01% | 0.0% |
Q1 2023 | $8,107,375 | -48.7% | 199,886 | -35.5% | 0.01% | -54.5% |
Q4 2022 | $15,793,106 | -10.2% | 309,851 | -5.2% | 0.02% | -12.0% |
Q3 2022 | $17,594,878 | -17.1% | 326,678 | -1.2% | 0.02% | -53.7% |
Q2 2022 | $21,232,000 | -67.0% | 330,555 | -60.2% | 0.05% | -59.4% |
Q1 2022 | $64,352,000 | -9.4% | 829,910 | +0.3% | 0.13% | -2.2% |
Q4 2021 | $71,009,000 | -11.4% | 827,218 | -17.0% | 0.14% | -15.0% |
Q3 2021 | $80,135,000 | +400.0% | 996,332 | +400.5% | 0.16% | +416.1% |
Q2 2021 | $16,027,000 | -13.7% | 199,087 | -9.6% | 0.03% | -16.2% |
Q1 2021 | $18,573,000 | +0.4% | 220,208 | -4.4% | 0.04% | 0.0% |
Q4 2020 | $18,491,000 | -12.8% | 230,451 | -12.6% | 0.04% | -21.3% |
Q3 2020 | $21,203,000 | -88.8% | 263,653 | -88.0% | 0.05% | -89.3% |
Q2 2020 | $189,814,000 | +4.3% | 2,204,581 | -1.6% | 0.44% | -10.0% |
Q1 2020 | $181,980,000 | -26.6% | 2,241,412 | -24.5% | 0.49% | -4.5% |
Q4 2019 | $248,091,000 | -5.4% | 2,966,888 | -1.0% | 0.51% | -10.6% |
Q3 2019 | $262,234,000 | +2.3% | 2,997,981 | -4.2% | 0.57% | +4.4% |
Q2 2019 | $256,346,000 | -0.4% | 3,129,994 | -1.1% | 0.55% | -4.8% |
Q1 2019 | $257,433,000 | +21.9% | 3,166,058 | -1.3% | 0.58% | +10.9% |
Q4 2018 | $211,170,000 | -26.4% | 3,208,300 | -13.8% | 0.52% | -11.7% |
Q3 2018 | $286,762,000 | +13.8% | 3,719,838 | +9.0% | 0.59% | +10.1% |
Q2 2018 | $251,931,000 | +480.9% | 3,411,849 | +411.6% | 0.54% | +476.3% |
Q1 2018 | $43,372,000 | -0.9% | 666,837 | -1.5% | 0.09% | +2.2% |
Q4 2017 | $43,749,000 | +265.3% | 676,824 | +254.7% | 0.09% | +250.0% |
Q3 2017 | $11,975,000 | +6.8% | 190,828 | +3.1% | 0.03% | +4.0% |
Q2 2017 | $11,208,000 | +17.4% | 185,126 | +0.6% | 0.02% | +13.6% |
Q1 2017 | $9,548,000 | +16.4% | 184,106 | -0.5% | 0.02% | +10.0% |
Q4 2016 | $8,204,000 | -4.4% | 185,017 | +2.7% | 0.02% | +25.0% |
Q3 2016 | $8,579,000 | -3.1% | 180,225 | -8.0% | 0.02% | -27.3% |
Q2 2016 | $8,854,000 | +3.6% | 195,807 | -5.9% | 0.02% | +4.8% |
Q1 2016 | $8,544,000 | +5.8% | 207,990 | -1.7% | 0.02% | +5.0% |
Q4 2015 | $8,073,000 | +14.0% | 211,633 | -1.8% | 0.02% | +11.1% |
Q3 2015 | $7,083,000 | -50.6% | 215,607 | +5.1% | 0.02% | -45.5% |
Q2 2015 | $14,346,000 | -38.7% | 205,149 | -40.0% | 0.03% | -36.5% |
Q1 2015 | $23,410,000 | +0.7% | 341,751 | +7.8% | 0.05% | 0.0% |
Q4 2014 | $23,244,000 | +4.3% | 317,146 | +2.1% | 0.05% | +2.0% |
Q3 2014 | $22,285,000 | -2.4% | 310,503 | -1.7% | 0.05% | -1.9% |
Q2 2014 | $22,828,000 | +2.1% | 315,731 | +3.9% | 0.05% | 0.0% |
Q1 2014 | $22,359,000 | +6.3% | 303,882 | +0.5% | 0.05% | +6.1% |
Q4 2013 | $21,036,000 | +8.2% | 302,458 | +2.2% | 0.05% | 0.0% |
Q3 2013 | $19,448,000 | -7.7% | 296,058 | -2.7% | 0.05% | -15.5% |
Q2 2013 | $21,077,000 | – | 304,268 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |